Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck Cancer

Summary

The purpose of this study is to provide access to paclitaxel therapy to subjects with advanced head and neck cancer who have completed the previous late phase 2 study (CA139-388) and should have continued therapy with paclitaxel as the discretion of the investigator, and to evaluate the frequency and the severity of observed adverse reactions in treated subjects

Timeline

Start

2006-08-04

Primary completion

2008-11-26

Completion

2008-11-26

Drugs

Indications